US Patent Issued to RIKEN on April 15 for "Hepatitis B virus replication inhibitor and pharmaceutical composition for treating hepatitis B comprising the same" (Japanese Inventor)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,759, issued on April 15, was assigned to RIKEN (Saitama, Japan).

"Hepatitis B virus replication inhibitor and pharmaceutical composition for treating hepatitis B comprising the same" was invented by Kenji Ogawa (Saitama, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The purpose of the invention is to develop and provide a novel therapeutic agent for hepatitis B that differs from the conventional therapeutic agent for hepatitis B in the mechanism of action, or target of interest. Provided is an inhibitor of hepatitis B virus replication consisting of a spike region in the core protein of a hepatitis B virus, or an expression vector containing a...